🧠AI AnalysisSELLAS Shares Surge Following Positive Phase 3 Leukemia Vaccine Trial Results
SELLAS Life Sciences stock tripled, reaching a new 52-week high after reporting that its experimental cancer vaccine reduced the risk of death in acute myeloid leukemia p…